Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-04-21

FDA Approved: PRIMIDONE — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved Amneal Pharmaceuticals LLC's supplemental application for Primidone, an anticonvulsant, under the ANDA process.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PRIMIDONE (Primidone)

Snippet

SUPPL AP for PRIMIDONE (PRIMIDONE)